Gold University of Minnesota M. Skip to main content.University of Minnesota. Home page.
 
OVPR Banner.
What's Inside
About OVPR

Policies, Regulations, and Compliance

Training

Information for Businesses

Funding Opportunities

Colleges, Centers, and Institutes

Communications

Forms and Electronic Tools  
Related Links

The Graduate School

Postdoctoral Affairs

Experts@Minnesota

Electronic Grants Management System (EGMS)

Academic Health Center Research

UM-Crookston Research

UM-Duluth Research

UM-Morris Research

 
 
Office of the Vice President for Research
Search OVPR | Contact OVPR  
  Home > Spotlight > Taylor

Taylor Made

U research opens a new path to replacement of hearts and other organs.



Doris Taylor

Integrative Biology and Physiology

PHOTO BY RICHARD ANDERSON






A rat heart in three stages of decellularization

A rat heart in three stages of decellularization via a process developed at the University by Taylor and her colleagues.


Watch the video


PHOTO BY THOMAS MATTHIESEN


In a medical first, University researchers have created a beating heart in the laboratory. Using detergents, they stripped away the cells from rat hearts until only the nonliving matrix was left; they then repopulated the matrix with fresh heart cells.


If perfected, the technique may be used someday to generate new hearts for patients. In the United States alone, about 5 million people live with heart failure, 550,000 new cases are diagnosed every year, and 50,000 die waiting for a donor heart. The work is published online in the January 13 issue of Nature Medicine.


"The results were a home run," says Doris Taylor, director of the University's Center for Cardiovascular Repair and a principal investigator on the study. "We knew that cell therapy--that is, transplanting cells into the heart--is not a panacea. So we started thinking, 'Is there a way to use cells to engineer heart tissue?'"

The idea, she says, is to create whole new blood vessels or organs by implanting a patient's own cells into a matrix derived from a donor organ. This approach ought to bypass the problem of organ rejection because the matrix, being devoid of cells, shouldn't provoke an immune response. Even if it did, the new cells would lay down a fresh matrix of their own, which would turn off the immune response and free patients from the need to take immunosuppressive drugs.


The process, called whole organ recellularization, can be done "with virtually any organ," Taylor says. "I'd like to think that these kinds of innovations will continue to happen at the U because the state realizes that we can change the world of medicine here in Minnesota."

By Deane Morrison

Excerpted from UMNnews, an e-publication of University Relations. View the full article.



OVPR Logo
 
The University of Minnesota is an equal opportunity educator and employer.